Index
1 Intravenous Immunoglobulin (IVIg) Market Overview
1.1 Product Overview and Scope of Intravenous Immunoglobulin (IVIg)
1.2 Intravenous Immunoglobulin (IVIg) Segment by Type
1.2.1 Global Intravenous Immunoglobulin (IVIg) Market Value Comparison by Type (2024-2030)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Intravenous Immunoglobulin (IVIg) Segment by Application
1.3.1 Global Intravenous Immunoglobulin (IVIg) Market Value by Application: (2024-2030)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Intravenous Immunoglobulin (IVIg) Market Size Estimates and Forecasts
1.4.1 Global Intravenous Immunoglobulin (IVIg) Revenue 2019-2030
1.4.2 Global Intravenous Immunoglobulin (IVIg) Sales 2019-2030
1.4.3 Global Intravenous Immunoglobulin (IVIg) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intravenous Immunoglobulin (IVIg) Market Competition by Manufacturers
2.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intravenous Immunoglobulin (IVIg) Average Price by Manufacturers (2019-2024)
2.4 Global Intravenous Immunoglobulin (IVIg) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Product Type & Application
2.7 Intravenous Immunoglobulin (IVIg) Market Competitive Situation and Trends
2.7.1 Intravenous Immunoglobulin (IVIg) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intravenous Immunoglobulin (IVIg) Players Market Share by Revenue
2.7.3 Global Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravenous Immunoglobulin (IVIg) Retrospective Market Scenario by Region
3.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intravenous Immunoglobulin (IVIg) Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2019-2030
3.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2019-2024
3.2.2 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2025-2030
3.3 Global Intravenous Immunoglobulin (IVIg) Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2019-2030
3.3.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2019-2024
3.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2025-2030
3.4 North America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.4.1 North America Intravenous Immunoglobulin (IVIg) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)
3.4.3 North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.5.1 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)
3.5.3 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.6.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)
3.6.3 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.7.1 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)
3.7.3 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2030)
4.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2024)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2025-2030)
4.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2019-2030)
4.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2019-2030)
4.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2019-2024)
4.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2025-2030)
4.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2019-2030)
4.3 Global Intravenous Immunoglobulin (IVIg) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2030)
5.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2024)
5.1.2 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2025-2030)
5.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2019-2030)
5.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2019-2030)
5.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2019-2024)
5.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2025-2030)
5.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2019-2030)
5.3 Global Intravenous Immunoglobulin (IVIg) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 CSL
6.3.1 CSL Corporation Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Intravenous Immunoglobulin (IVIg) Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Biotest
6.5.1 Biotest Corporation Information
6.5.2 Biotest Description and Business Overview
6.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio
6.5.5 Biotest Recent Developments/Updates
6.6 Kedrion
6.6.1 Kedrion Corporation Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio
6.6.5 Kedrion Recent Developments/Updates
6.7 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio
6.7.5 Hualan Bio Recent Developments/Updates
6.8 CNBG
6.8.1 CNBG Corporation Information
6.8.2 CNBG Description and Business Overview
6.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio
6.8.5 CNBG Recent Developments/Updates
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Corporation Information
6.9.2 Shanghai RAAS Description and Business Overview
6.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio
6.9.5 Shanghai RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Corporation Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 LFB Group
6.11.1 LFB Group Corporation Information
6.11.2 LFB Group Intravenous Immunoglobulin (IVIg) Description and Business Overview
6.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio
6.11.5 LFB Group Recent Developments/Updates
6.12 BPL
6.12.1 BPL Corporation Information
6.12.2 BPL Intravenous Immunoglobulin (IVIg) Description and Business Overview
6.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 BPL Intravenous Immunoglobulin (IVIg) Product Portfolio
6.12.5 BPL Recent Developments/Updates
6.13 Sichuan Yuanda Shuyang
6.13.1 Sichuan Yuanda Shuyang Corporation Information
6.13.2 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Description and Business Overview
6.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio
6.13.5 Sichuan Yuanda Shuyang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Immunoglobulin (IVIg) Industry Chain Analysis
7.2 Intravenous Immunoglobulin (IVIg) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Immunoglobulin (IVIg) Production Mode & Process
7.4 Intravenous Immunoglobulin (IVIg) Sales and Marketing
7.4.1 Intravenous Immunoglobulin (IVIg) Sales Channels
7.4.2 Intravenous Immunoglobulin (IVIg) Distributors
7.5 Intravenous Immunoglobulin (IVIg) Customers
8 Intravenous Immunoglobulin (IVIg) Market Dynamics
8.1 Intravenous Immunoglobulin (IVIg) Industry Trends
8.2 Intravenous Immunoglobulin (IVIg) Market Drivers
8.3 Intravenous Immunoglobulin (IVIg) Market Challenges
8.4 Intravenous Immunoglobulin (IVIg) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer